Patent application number | Description | Published |
20090055555 | METHOD AND SYSTEM FOR FLEXIBLE AND NEGOTIABLE EXCHANGE OF LINK LAYER FUNCTIONAL PARAMETERS - A proposal is discussed that facilitates exchanging parameters for a link layer that allows a variable number of parameters without changing a communication protocol. Likewise, the proposal allows for both components connected via the link to negotiate values for the parameters that are exchanged without a need for external agent intervention or redundancy. | 02-26-2009 |
20090063813 | METHOD AND SYSTEM FOR FLEXIBLE AND NEGOTIABLE EXCHANGE OF LINK LAYER FUNCTIONAL PARAMETERS - A proposal is discussed that facilitates exchanging parameters for a link layer that allows a variable number of parameters without changing a communication protocol. Likewise, the proposal allows for both components connected via the link to negotiate values for the parameters that are exchanged without a need for external agent intervention or redundancy. | 03-05-2009 |
20090064179 | METHOD AND SYSTEM FOR FLEXIBLE AND NEGOTIABLE EXCHANGE OF LINK LAYER FUNCTIONAL PARAMETERS - A proposal is discussed that facilitates exchanging parameters for a link layer that allows a variable number of parameters without changing a communication protocol. Likewise, the proposal allows for both components connected via the link to negotiate values for the parameters that are exchanged without a need for external agent intervention or redundancy. | 03-05-2009 |
20100027564 | Method, Apparatus, And System For Idle State Definition For Power Management - A predetermined network packet is utilized for power reduction in either or both of a transmitter and receiver when information is not needed. Upon detection of the predetermined network packet type, various portions of the transmitter and/or receiver may be clock gated or powered down. | 02-04-2010 |
20100191890 | Globally Unique Transaction Identifiers - In one embodiment of the present invention, a method includes identifying a transaction from a first processor to a second processor of a system with a transaction identifier. The transaction identifier may have a value that is less than or equal to a maximum number of outstanding transactions between the two processors. In such manner, a transaction field for the transaction identifier may be limited to n bits, where the maximum number of outstanding transactions is less than or equal to 2 | 07-29-2010 |
20100332686 | WRITE COMBINING PROTOCOL BETWEEN PROCESSORS AND CHIPSETS - Systems and methods of processing write transactions provide for combining write transactions on an input/output (I/O) hub according to a protocol between the I/O hub and a processor. Data associated with the write transactions can be flushed to an I/O device without the need for proprietary software and specialized registers within the I/O device. | 12-30-2010 |
20120011276 | Dynamically Modulating Link Width - Systems and methods of managing a link provide for receiving a remote width capability during a link initialization, the remote width capability corresponding to a remote port. A link between a local port and the remote port is operated at a plurality of link widths in accordance with the remote width capability. | 01-12-2012 |
20130070779 | Interleaving Data Packets In A Packet-Based Communication System - In one embodiment, the present invention includes a method for receiving a first portion of a first packet at a first agent and determining whether the first portion is an interleaved portion based on a value of an interleave indicator. The interleave indicator may be sent as part of the first portion. In such manner, interleaved packets may be sent within transmission of another packet, such as a lengthy data packet, providing improved processing capabilities. Other embodiments are described and claimed. | 03-21-2013 |
20140112339 | HIGH PERFORMANCE INTERCONNECT - A physical layer (PHY) is coupled to a serial, differential link that is to include a number of lanes. The PHY includes a transmitter and a receiver to be coupled to each lane of the number of lanes. The transmitter coupled to each lane is configured to embed a clock with data to be transmitted over the lane, and the PHY periodically issues a blocking link state (BLS) request to cause an agent to enter a BLS to hold off link layer flit transmission for a duration. The PHY utilizes the serial, differential link during the duration for a PHY associated task selected from a group including an in-band reset, an entry into low power state, and an entry into partial width state | 04-24-2014 |
20140115268 | HIGH PERFORMANCE INTERCONNECT COHERENCE PROTOCOL - A coherence protocol message is sent corresponding to a particular cache line. A potential conflict involving the particular cache line is identified and a forward request is sent to a home agent to identify the potential conflict. A forward response can be received in response to the forward request from the home agent and a response to the conflict can be determined. | 04-24-2014 |
20150081921 | DYNAMICALLY MODULATING LINK WIDTH - Systems and methods of managing a link provide for receiving a remote width capability during a link initialization, the remote width capability corresponding to a remote port. A link between a local port and the remote port is operated at a plurality of link widths in accordance with the remote width capability. | 03-19-2015 |
20150089161 | HIGH PERFORMANCE INTERCONNECT COHERENCE PROTOCOL - A coherence protocol message is sent corresponding to a particular cache line. A potential conflict involving the particular cache line is identified and a forward request is sent to a home agent to identify the potential conflict. A forward response can be received in response to the forward request from the home agent and a response to the conflict can be determined. | 03-26-2015 |
Patent application number | Description | Published |
20100239554 | EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME - The present invention relates to compositions comprising biologically active proteins linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of using such compositions in treatment of glucose-related diseases, metabolic diseases, coagulation disorders, and growth hormone-related disorders and conditions. | 09-23-2010 |
20110046060 | Coagulation factor IX compositions and methods of making and using same - The present invention relates to compositions comprising factor IX coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of coagulation factor-related diseases, disorders, and conditions. | 02-24-2011 |
20110046061 | Coagulation factor VII compositions and methods of making and using same - The present invention relates to compositions comprising factor VII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of coagulation factor-related diseases, disorders, and conditions. | 02-24-2011 |
20120178691 | FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME - The present invention relates to compositions comprising factor VIII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of factor VIII-related diseases, disorders, and conditions. | 07-12-2012 |
20120263701 | COAGULATION FACTOR VII COMPOSITIONS AND METHODS OF MAKING AND USING SAME - The present invention relates to compositions comprising factor VII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of coagulation factor-related diseases, disorders, and conditions. | 10-18-2012 |
20130017997 | Factor VIII Compositions and Methods of Making and Using Same - The present invention relates to compositions comprising factor VIII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of factor VIII-related diseases, disorders, and conditions. | 01-17-2013 |
20130165389 | BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS OF MAKING AND USING SAME - The present invention relates to binding fusion protein compositions comprising targeting moieties linked to extended recombinant polypeptide (XTEN), binding fusion protein-drug conjugate compositions, and XTEN-drug conjugate compositions, isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of using such compositions in treatment of diseases, disorders, and conditions. | 06-27-2013 |
20140162949 | TREATMENT WITH HUMAN GROWTH HORMONE ANALOGUES - The present invention concerns an improved therapeutic regimen for GHD therapy. In particular, the invention concerns methods for bolus dose administration of a human growth hormone-XTEN (hGH-XTEN) fusion protein. | 06-12-2014 |
20140186327 | COAGULATION FACTOR IX COMPOSITIONS AND METHODS OF MAKING AND USING SAME - The present invention relates to compositions comprising factor IX coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of coagulation factor-related diseases, disorders, and conditions. | 07-03-2014 |
20140301974 | EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME - The present invention relates to compositions comprising biologically active proteins linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of using such compositions in treatment of glucose-related diseases, metabolic diseases, coagulation disorders, and growth hormone-related disorders and conditions. | 10-09-2014 |
20140328819 | COAGULATION FACTOR VII COMPOSITIONS AND METHODS OF MAKING AND USING SAME - The present invention relates to compositions comprising factor VII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of coagulation factor-related diseases, disorders, and conditions. | 11-06-2014 |
20150038421 | FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME - The present invention relates to compositions comprising factor VIII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of factor VIII-related diseases, disorders, and conditions. | 02-05-2015 |